Zala, CarlosHarris, MarianneOchoa, ClaudiaTocci, MarielQuercia, RominaMittelman, GracielaGraciela, HéctorCahn, PedroMontaner, Julio SG2024-05-232024-05-232002-12https://doi.org/10.1177/135965350200700412https://repositorio.huesped.org.ar/handle/123456789/1361Fil: Zala C. Fundación Huésped, Buenos Aires; ArgentinaFil: Ochoa C. Fundación Huésped, Buenos Aires; ArgentinaFil: Cahn P. Fundación Huésped, Buenos Aires; ArgentinaHyperlactataemia is increasingly recognised as a complication of nucleoside analogue-based antiretroviral therapy [1–5]. There is, however, some debate about the accuracy of peripheral venous blood lactate levels and whether these adequately reflect arterial lactate levels. This correlation has been demonstrated in the non-HIV, emergency medicine literature [6,7], but has not been studied in HIV patients receiving antiretroviral therapy. Therefore, we undertook the present study to compare venous versus arterial lactate levels in HIV patients who had consistently high random venous lactate while receiving chronic stavudine-based antiretroviral therapy.application/pdfopenAccessHIVArticulo